Clinical Trials List
Protocol NumberACT16849
2021-09-01 - 2025-12-31
Phase II
Terminated3
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yung-Hung Luo Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
- Chi-Lu Chiang Division of Thoracic Medicine
- Heng-Sheng Chao Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jui-Hung Tsai Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Po-Lan Su Division of General Internal Medicine
- Yu-Min Yeh Division of Hematology & Oncology
- Chien-Chung Lin Division of General Internal Medicine
- Wen-Pin Su Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Yen Tu Division of Thoracic Medicine
- 廖偉志 無
- Chen Chia-Hung Division of Thoracic Medicine
- 陳鴻仁 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
300 participants
